Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models
暂无分享,去创建一个
John F. Fraser | Adrian G. Barnett | Kiran Shekar | Sara Diab | Jason A. Roberts | J. Fraser | A. Barnett | J. Roberts | S. Diab | Y. Fung | Steven C. Wallis | Yoke L. Fung | K. Shekar | S. Wallis
[1] J. Vincent,et al. Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study , 2014, Critical Care.
[2] J. Roberts,et al. Pharmacokinetic issues for antibiotics in the critically ill patient , 2009, Critical care medicine.
[3] M. Buck. Pharmacokinetic Changes During Extracorporeal Membrane Oxygenation , 2003, Clinical pharmacokinetics.
[4] D. Kaufman,et al. Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[5] Frédérique Jacobs,et al. β-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: A case-control study. , 2015, International journal of antimicrobial agents.
[6] J. Fraser,et al. The role of echocardiography in the management of patients supported by extracorporeal membrane oxygenation. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[7] G. Koren,et al. Preliminary Studies of the Effects of Extracorporeal Membrane Oxygenator on the Disposition of Common Pediatric Drugs , 1993, Therapeutic drug monitoring.
[8] J. Fraser,et al. Effect of smoke inhalation on viscoelastic properties and ventilation distribution in sheep. , 2006, Journal of applied physiology.
[9] P. Hinderling,et al. The pH Dependency of the Binding of Drugs to Plasma Proteins in Man , 2005, Therapeutic drug monitoring.
[10] H. Neumayer,et al. Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease , 1984, European Journal of Drug Metabolism and Pharmacokinetics.
[11] J. J. Fins,et al. Extracorporeal membrane oxygenation for ARDS in adults. , 2012, The New England journal of medicine.
[12] S. Chauhan,et al. Extracorporeal membrane oxygenation, an anesthesiologist's perspective: physiology and principles. Part 1. , 2011, Annals of cardiac anaesthesia.
[13] Kiran Shekar,et al. Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation , 2012, Critical Care.
[14] W. Butt,et al. Extracorporeal membrane oxygenation and sepsis. , 2007, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[15] David S. Wishart,et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..
[16] Kiran Shekar,et al. The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study , 2014, Critical Care.
[17] O. Cars,et al. Protein Binding: Do We Ever Learn? , 2011, Antimicrobial Agents and Chemotherapy.
[18] D. Pilcher,et al. Infections Acquired by Adults Who Receive Extracorporeal Membrane Oxygenation Risk Factors and Outcome , 2013, Infection Control & Hospital Epidemiology.
[19] J. Fraser,et al. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. , 2012, Journal of critical care.
[20] Kiran Shekar,et al. ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO , 2012, BMC Anesthesiology.
[21] J. Fraser,et al. Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study , 2015, Critical Care.
[22] D. Schoenfeld,et al. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. , 2000, The New England journal of medicine.
[23] Bruce Thomson,et al. Extracorporeal life support devices and strategies for management of acute cardiorespiratory failure in adult patients: a comprehensive review , 2014, Critical Care.
[24] D. Brodie,et al. Extracorporeal membrane oxygenation in cardiopulmonary disease in adults. , 2014, Journal of the American College of Cardiology.
[25] A. Combes,et al. Impact of Extracorporeal Membrane Oxygenation and Continuous Venovenous Hemodiafiltration on the Pharmacokinetics of Oseltamivir Carboxylate in Critically Ill Patients With Pandemic (H1N1) Influenza , 2012, Therapeutic drug monitoring.
[26] T F Blaschke,et al. Gentamicin pharmacokinetics in neonates undergoing extracorporal membrane oxygenation , 1990, The Pediatric infectious disease journal.
[27] David Stewart,et al. Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactions. , 2012, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.
[28] Ryan P. Barbaro,et al. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry. , 2015, American journal of respiratory and critical care medicine.
[29] Kiran Shekar,et al. The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation , 2013, BMC Anesthesiology.
[30] D. Paterson,et al. Antibiotic resistance—What’s dosing got to do with it? , 2008, Critical care medicine.
[31] K. Shekar. Extracorporeal Respiratory Support: Breaking Conventions? , 2014, Anaesthesia and intensive care.